Used in research settings as a selective antagonist for the GPR109A receptor, which is involved in lipid metabolism and inflammation pathways. It helps scientists study niacin-mediated effects, particularly in understanding mechanisms related to cholesterol regulation and anti-inflammatory responses. Commonly applied in cellular and in vivo models to investigate metabolic diseases, atherosclerosis, and immune modulation. Not intended for clinical or therapeutic use in humans.